North America blood plasma market will expand with a CAGR of 6.00% in the estimated years from 2019-2027
The United States and Canada together form the market for blood plasma in the North American region. In addition to its usage in the treatment of chronic diseases, blood plasma offers other opportunities. The potential advantages offered by blood plasma are being explored to their fullest by various research organizations in Canada.
For instance, the Orange County Hair Restoration Center, a part of the Irvine Institute of Medicine and Cosmetic Surgery, is a state-of-the-art facility that performs cosmetic hair restoration surgeries. The company, based in Canada, has expertise in treating hair loss, as well as scalp disorders. The center has incorporated the PRP or platelet-rich plasma therapy for the treating hair loss as a proactive method for both, the male, as well as female patients.
The platelet-rich plasma therapy proves beneficial for patients requiring stimulation of hair growth and is the preferred method of treatment by physicians, as it is an all-natural autologous medical procedure for scalp restoration, skin rejuvenation and hair stimulation. This shows that the market for blood plasma has immense opportunities for growth in Canada.
Key Topics Covered:
1. North America Blood Plasma Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.3. Vendor Scorecard
2.4. Clinical Guidelines
2.5. Regulation in the Plasma Therapeutics
2.6. Key Insights
2.7. Regulatory Outlook
2.8. Market Trends
2.9. Market Drivers
2.9.1. Expansion in Indication for New Therapeutic Areas
2.9.2. Approval of Immunoglobulin-Centered Therapies
2.9.3. Surge in the Hemophilia Treatment
2.10. Market Restraints
2.10.1. High Costs of Blood Plasma Treatments
2.10.2. Easy Availability of Recombinant Plasma
2.11. Market Opportunities
2.11.1. Increasing Public Cognizance
2.11.2. Rise in the Plasma-Derived Products Opportunities
2.11.3. Increasing Occurrence of Hemophilia
2.12. Market Challenges
2.12.1. Spread of Pathogenic Contaminants
2.12.2. High Regulations in the Market
2.13. Blood Plasma Industry by Mode of Delivery
2.13.1. Infusion Solutions
2.13.4. Biomedical Sealants
3. Blood Plasma Market Outlook - by Blood Type
3.2.1. Intravenous Immunoglobulin
3.2.2. Subcutaneous Immunoglobulin
3.2.3. Other Immunoglobulin Type
3.3. Coagulation Factor Concentrates
3.5. Other Plasma Fractionation Products
4. Blood Plasma Market Outlook - by Application
4.8. Other Applications
5. Blood Plasma Market Outlook - by End-User
5.1. Academic Institutions
5.2. Research Laboratories
5.3. Hospitals and Clinics
6. Blood Plasma Market - Regional Outlook
6.1. North America
6.1.1. Country Analysis
126.96.36.199. The United States
7. Company Profiles
7.1. Shire plc
7.3. Octapharma AG
7.4. Baxter International, Inc.
7.5. Grifols International S.A.
7.6. Biotest AG
7.7. Csl Ltd.
7.8. Adma Biologics, Inc.
7.9. China Biologic Products, Inc.
7.10. General Electric Co.
7.11. Cerus Corp.
For more information about this report visit https://www.researchandmarkets.com/r/s790u6